Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Na Qiu, Akshaya Srikanth, Medhanie Mulaw, Umesh Tharehalli, Shanthiya Selvachandran, Martin Wagner, Thomas Seufferlein, Katja Stifter, André Lechel & Reinhold Schirmbeck. (2023) CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variants. OncoImmunology 12:1.
Read now
Read now
Yu-Li Su, Ca Tung Ng, Yi-Hua Jan, Yi-Lin Hsieh, Chia-Ling Wu & Kien Thiam Tan. (2021) Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation. OncoTargets and Therapy 14, pages 3895-3901.
Read now
Read now
Tong Liu, Sainan Li, Liwei Wu, Qiang Yu, Jingjing Li, Jiao Feng, Jie Zhang, Jiaojiao Chen, Yuting Zhou, Jie Ji, Kan Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Xiaoming Fan, Jianye Wu & Chuanyong Guo. (2020) Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2. Journal of Hepatocellular Carcinoma 7, pages 19-31.
Read now
Read now
Articles from other publishers (67)
Brandon Goodwin, Johanna Lou, Margaret Butchy, Traeden Wilson, Umur Atabek, Francis Spitz & Young Hong. (2022) Hepatocellular-Cholangiocarcinoma Collision Tumors: An Update of Current Management Practices. The American Surgeon™ 89:6, pages 2685-2692.
Crossref
Crossref
Yu-Ting Shen, Wen-Wen Yue & Hui-Xiong Xu. (2023) Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma. Abdominal Radiology 48:6, pages 2019-2037.
Crossref
Crossref
Anita Bakrania, Narottam Joshi, Xun Zhao, Gang Zheng & Mamatha Bhat. (2023) Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases. Pharmacological Research 189, pages 106706.
Crossref
Crossref
L Choi, JY Choi, HY Yoon, K Bae, KA Yoon & JH Kim. (2023) Adjuvant therapy with toceranib for hepatocellular carcinoma and cholangiocarcinoma in a Pomeranian. Veterinární medicína 68:2, pages 83-89.
Crossref
Crossref
Shoma Berkemeyer. (2023) Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with Metabolomics. International Journal of Molecular Sciences 24:3, pages 2409.
Crossref
Crossref
Marcus Bahra & Ali Yahyazadeh. (2023) Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC). Cancers 15:3, pages 774.
Crossref
Crossref
Fei-Qi Xu, Meng-Meng Dong, Zhi-Fei Wang & Li-Dong Cao. (2023) Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Crossref
Sang-Won Kim, Ju-Won Choi, Jeon-Mo Kim, Hun-Young Yoon, Kieun Bae, Kyong-Ah Yoon & Jung-Hyun Kim. (2023) Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma. Frontiers in Veterinary Science 9.
Crossref
Crossref
Johannes Eschrich, Zuzanna Kobus, Dominik Geisel, Sebastian Halskov, Florian Roßner, Christoph Roderburg, Raphael Mohr & Frank Tacke. (2023) The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives. Cancers 15:1, pages 301.
Crossref
Crossref
Elena Sapuppo, Oronzo Brunetti, Dalila Tessitore, Giovanni Brandi, Nicola Di Giovanni, Guido Fadda, Claudio Luchini, Maurizio Martini, Davide Quaresmini, Antonio Russo, Mariacarmela Santarpia, Aldo Scarpa, Mario Scartozzi, Giovanni Tuccari, Tindara Franchina & Nicola Silvestris. (2023) Rare histotypes of epithelial biliary tract tumors: A literature review. Critical Reviews in Oncology/Hematology 181, pages 103892.
Crossref
Crossref
Ihtzaz Ahmed Malik, Mansi Rajput, Rieke Werner, Dorothea Fey, Niloofar Salehzadeh, Christine A. F. von Arnim & Jörg Wilting. (2022) Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer. BMC Cancer 22:1.
Crossref
Crossref
Yang Wu, Chao-Bang Xie, Yi-Huai He, Di Ke, Qiong Huang, Kai-Fei Zhao & Rong-Shu Shi. (2022) Three-in-one incidence of hepatocellular carcinoma, cholangiocellular carcinoma, and neuroendocrine carcinoma: A case report. World Journal of Clinical Cases 10:29, pages 10575-10582.
Crossref
Crossref
Sean H. KimBenjamin NavotPreethi GunigantiAlexander GavlinElizabeth M. HechtAndrea S. Kierans. (2022) Liver Transplant for Nonhepatocellular Malignancies: A Review for Radiologists. American Journal of Roentgenology 219:4, pages 590-603.
Crossref
Crossref
Fangyuan Li, Ting Zheng & Xuewei Gu. (2022) Prognostic risk factor analysis and nomogram construction for primary liver cancer in elderly patients based on SEER database. BMJ Open 12:10, pages e051946.
Crossref
Crossref
Dina Sweed, Enas Sweed, Inas Moaz, Asmaa Mosbeh, Yahya Fayed, Sara Mohamed Abd Elhamed, Eman Sweed, Mahmoud Macshut, Shimaa Abdelsattar, Shimaa Kilany, Sara A. Saied, Reda Badr, Mahmoud S. Abdallah & Nermine Ehsan. (2022) The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Rebecca Jeyaraj & Deirdre Kelly. (2022) Rare Inherited Cholestatic Disorders and Molecular Links to Hepatocarcinogenesis. Cells 11:16, pages 2570.
Crossref
Crossref
Changwu Zhou, Xin Lu, Yi Wang, Xianling Qian, Chun Yang & Mengsu Zeng. (2022) Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. European Radiology 32:10, pages 6702-6711.
Crossref
Crossref
Joon Hyuk Choi & Jae Y. Ro. (2022) Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach. Biomedicines 10:8, pages 1826.
Crossref
Crossref
Parveez Ahamed Abdul Azees, Suganthy Natarajan, Bennett T. Amaechi, Nooruddin Thajuddin, Vinay B. Raghavendra, Kathirvel Brindhadevi, Arivalagan Pugazhendhi & Tran Nhat Phuong. (2022) An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies. Process Biochemistry 118, pages 283-293.
Crossref
Crossref
Yu-Wen Zhou, Qing-Fang Li, Yue-Yun Chen, Kai Wang, Dan Pu, Xiao-Rong Chen, Chun-Hong Li, Li Jiang, Yan Wang, Qiu Li, Yu Yang, Hong-Feng Gou, Feng Bi, Ji-Yan Liu, Ye Chen & Meng Qiu. (2022) Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study. European Journal of Surgical Oncology 48:7, pages 1559-1566.
Crossref
Crossref
Yan Zhou, Shanshan Yin, Lin Zhao, Xiang Zhang, Meng Li, Jianmin Ding, Kun Yan & Xiang Jing. (2022) CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Ling Gao, Jia-Yan Huang, Zi-Jian Lu & Qiang Lu. (2022) Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: A case report. World Journal of Clinical Cases 10:11, pages 3615-3623.
Crossref
Crossref
Carmen Cutolo, Federica Dell’Aversana, Roberta Fusco, Giulia Grazzini, Giuditta Chiti, Igino Simonetti, Federico Bruno, Pierpaolo Palumbo, Luca Pierpaoli, Tommaso Valeri, Francesco Izzo, Andrea Giovagnoni, Roberto Grassi, Vittorio Miele, Antonio Barile & Vincenza Granata. (2022) Combined Hepatocellular-Cholangiocarcinoma: What the Multidisciplinary Team Should Know. Diagnostics 12:4, pages 890.
Crossref
Crossref
Yang Yang, Pengwei Ren, Xiaofeng Liu, Xiaoyan Sun, Chunfeng Zhang, Xiaojuan Du & Baocai Xing. (2022) PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Evgenii A. Zherebtsov, Elena V. Potapova, Andrian V. Mamoshin, Valery V. Shupletsov, Ksenia Y. Kandurova, Viktor V. Dremin, Andrey Y. Abramov & Andrey V. Dunaev. (2022) Fluorescence lifetime needle optical biopsy discriminates hepatocellular carcinoma. Biomedical Optics Express 13:2, pages 633.
Crossref
Crossref
Xuehu Wang, Shuping Wang, Xiaoping Yin & Yongchang Zheng. (2022) MRI-based radiomics distinguish different pathological types of hepatocellular carcinoma. Computers in Biology and Medicine 141, pages 105058.
Crossref
Crossref
Sungjin Ko, Minwook Kim, Laura Molina, Alphonse E. Sirica & Satdarshan P. Monga. 2022. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Hepatobiliary Cancers: Translational Advances and Molecular Medicine
283
317
.
Elizabeth Richardson & Scott Fink. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
183
195
.
Daw-Shyong Perng, Chao-Ming Hung, Hung-Yu Lin, Paul Morgan, Yao-Chun Hsu, Tsung-Chin Wu, Pei-Min Hsieh, Jen-Hao Yeh, Pojen Hsiao, Chih-Yuan Lee, Yu-Chan Li, Ya-Chin Wang, Yaw-Sen Chen & Chih-Wen Lin. (2021) Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection. BMC Cancer 21:1.
Crossref
Crossref
Sang Hyun Choi, Sun Kyung Jeon, Seung Soo Lee, Jeong Min Lee, Bo Yun Hur, Hyo-Jin Kang, Haeryoung Kim & Yangsoon Park. (2021) Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI. European Radiology 31:12, pages 9479-9488.
Crossref
Crossref
Wan Sun, Changchang Hu, Tianyu Wang, Juan Wang, Jieping Zhang, Furong Gao, Qingjian Ou, Haibin Tian, Caixia Jin, Jingying Xu, Jingfa Zhang, Guo-Tong Xu & Lixia Lu. (2021) Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Gui-Min Hou, Hai-ling Liu, Hong Wu & Yong Zeng. (2021) Prediction of Prognosis for cHCC-CC Patients After Surgery: Comparison of Tumor Marker Score Based on AFP, CEA, CA19-9, and Other Clinical Stages. Annals of Surgical Oncology 28:12, pages 7647-7660.
Crossref
Crossref
Karthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, Jay A. Moore, James Pao, Dean C. Pavlick, Garrett M. Frampton, Vivek A. Upadhyay, Brian M. Alexander, Vincent A. Miller, Milind M. Javle, Tanios S. Bekaii Saab, Lee A. Albacker, Jeffrey S. Ross & Siraj M. Ali. (2021) Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma. JCO Precision Oncology:5, pages 1285-1296.
Crossref
Crossref
Chih‐Chieh Yen, Chia‐Jui Yen, Yan‐Shen Shan, Yih‐Jyh Lin, I‐Ting Liu, Hsuan‐Yi Huang, Matthew M Yeh, Shih‐Huang Chan & Hung‐Wen Tsai. (2021) Comparing the clinicopathological characteristics of combined hepatocellular–cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. Histopathology 79:4, pages 556-572.
Crossref
Crossref
Po-Da Chen, Li-Ju Chen, Yao-Jen Chang & Yun-Jau Chang. (2021) Long-Term Survival of Combined Hepatocellular-Cholangiocarcinoma: A Nationwide Study. The Oncologist 26:10, pages e1774-e1785.
Crossref
Crossref
Mohamad F Ayas, Saif Affas, Zayd Ayas, Momal Chand & Tarik Hadid. (2021) Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer. Cureus.
Crossref
Crossref
Roberto Cannella, Guilherme Moura Cunha, Roberta Catania, Kalina Chupetlovska, Amir A. Borhani, Kathryn J. Fowler & Alessandro Furlan. (2021) Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver Disease. Magnetic Resonance Imaging Clinics of North America 29:3, pages 404-418.
Crossref
Crossref
Thiyaphat Laohawetwanit, Nathawadee Lerttanatum, Natcha Wanpiyarat, Natcha Manasilp & Sirawich Chaiparnich. (2021) Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology. Annals of Diagnostic Pathology 53, pages 151770.
Crossref
Crossref
Jie Yang, Jia-Yan Huang, Xing Chen, Wen-Wu Ling, Yan Luo, Yu-Jun Shi, Ji-Bin Liu, Qiang Lu & Andrej Lyshchik. (2021) Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient’s survival?. European Radiology 31:8, pages 6397-6405.
Crossref
Crossref
Matteo Renzulli, Daryl Ramai, Jameel Singh, Samridhi Sinha, Nicolò Brandi, Anna Maria Ierardi, Elisa Albertini, Rodolfo Sacco, Antonio Facciorusso & Rita Golfieri. (2021) Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma. Cancers 13:13, pages 3336.
Crossref
Crossref
Aurélie Beaufrère, Julien Calderaro & Valérie Paradis. (2021) Combined hepatocellular-cholangiocarcinoma: An update. Journal of Hepatology 74:5, pages 1212-1224.
Crossref
Crossref
Yiannis Petros Dimopoulos, Emily R Winslow, Aiwu Ruth He & Metin Ozdemirli. (2021) Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report. World Journal of Clinical Oncology 12:4, pages 262-271.
Crossref
Crossref
Oraianthi Fiste, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Michalis Liontos, Konstantinos Koutsoukos, Meletios Athanasios Dimopoulos & Flora Zagouri. (2021) The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma. Vaccines 9:5, pages 422.
Crossref
Crossref
Brandon Swed, Omar Gandarilla, Kenrry Chiu, Karim H. Halazun, Benjamin Samstein, Rhonda Yantiss & Gagandeep Brar. (2021) Rare Histological Variants of Liver Cancer and Their Management: A Single-Institution Experience. Case Reports in Hepatology 2021, pages 1-7.
Crossref
Crossref
Atsushi Nanashima, Kunihiko Tominaga, Akihiro Yonei, Ryo Sekiya, Syoutaro Oshikawa, Yuichiro Sato, Norio Wake & Jun Akiba. (2020) A rare case of intrahepatic cholangiocarcinoma with tumor thrombus in the bile duct. Clinical Journal of Gastroenterology 14:1, pages 275-282.
Crossref
Crossref
Minjae Kim, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park & Seung-Mo Hong. (2021) Postresection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma according to the 2010 World Health Organization classification: single-center experience of 168 patients. Annals of Surgical Treatment and Research 100:5, pages 260.
Crossref
Crossref
Victoria Wu, Mark A. McArthur, Amanda Allen, Luis Manon & Karen L. Xie. (2021) Rare primary hepatic malignancies: A case-based review. Clinical Imaging 69, pages 196-204.
Crossref
Crossref
Alphonse E. Sirica, Mario Strazzabosco & Massimiliano Cadamuro. 2021. Mechanisms and Therapy of Liver Cancer. Mechanisms and Therapy of Liver Cancer
321
387
.
Xiaoyang Liu, Farzad Khalvati, Khashayar Namdar, Sandra Fischer, Sara Lewis, Bachir Taouli, Masoom A. Haider & Kartik S. Jhaveri. (2020) Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?. European Radiology 31:1, pages 244-255.
Crossref
Crossref
Elizabeth Richardson & Scott Fink. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
1
13
.
Jiao Feng, Jingjing Li, Liwei Wu, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai & Chuanyong Guo. (2020) Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Takamichi Ishii, Takashi Ito, Shinji Sumiyoshi, Satoshi Ogiso, Ken Fukumitsu, Satoru Seo, Kojiro Taura & Shinji Uemoto. (2020) Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Dimitrios Schizas, Aikaterini Mastoraki, Eleni Routsi, Michail Papapanou, Dimitrios Tsapralis, Pantelis Vassiliu, Konstantinos Toutouzas & Evangelos Felekouras. (2020) Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary & Pancreatic Diseases International 19:6, pages 515-523.
Crossref
Crossref
Olga Raevskaya, Henry Appelman & Nataliya Razumilava. (2020) A Contemporary Approach to Diagnosis and Treatment of Combined Hepatocellular-Cholangiocarcinoma. Current Hepatology Reports 19:4, pages 478-485.
Crossref
Crossref
Angélique Vienot & Cindy Neuzillet. (2020) Continuum of care for advanced biliary tract cancers. Clinics and Research in Hepatology and Gastroenterology 44:6, pages 810-824.
Crossref
Crossref
Qi Zhao, Maria del Pilar Molina-Portela, Asma Parveen, Alexander Adler, Christina Adler, Hock E, Wei Wang, Min Ni, Yi Wei, Gurinder Atwal, Markus Mohrs, Gavin Thurston & Alexandra Eichten. (2020) Heterogeneity and chimerism of endothelial cells revealed by single-cell transcriptome in orthotopic liver tumors. Angiogenesis 23:4, pages 581-597.
Crossref
Crossref
Alexander A. Azizi, Andreas V. Hadjinicolaou, Carla Goncalves, Adam Duckworth & Bristi Basu. (2020) Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Yuting Peng, Peng Lin, Linyong Wu, Da Wan, Yujia Zhao, Li Liang, Xiaoyu Ma, Hui Qin, Yichen Liu, Xin Li, Xinrong Wang, Yun He & Hong Yang. (2020) Ultrasound-Based Radiomics Analysis for Preoperatively Predicting Different Histopathological Subtypes of Primary Liver Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Damiano Gentile, Matteo Donadon, Luca Di Tommaso, Laura Samà, Eloisa Franchi, Guido Costa, Ana Lleo & Guido Torzilli. (2020) Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis. Updates in Surgery 72:3, pages 671-679.
Crossref
Crossref
Tao Wang, Xianwei Yang, Huairong Tang, Junjie Kong, Shu Shen, Haizhou Qiu & Wentao Wang. (2020) Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection. Aging 12:15, pages 15334-15358.
Crossref
Crossref
Kyohei Yugawa, Kenichi Kohashi, Shinji Itoh, Tomoharu Yoshizumi, Ichiro Sakamoto, Hiroyuki Tsutsui, Masaki Mori & Yoshinao Oda. (2020) Combined hepatocellular-cholangiocarcinoma after tetralogy of Fallot repair: a case report and review of literature. Pathology - Research and Practice 216:5, pages 152908.
Crossref
Crossref
Amanda J. Craig, Johann von Felden, Teresa Garcia-Lezana, Samantha Sarcognato & Augusto Villanueva. (2019) Tumour evolution in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 17:3, pages 139-152.
Crossref
Crossref
Giovanni Brandi & Simona Tavolari. (2020) Asbestos and Intrahepatic Cholangiocarcinoma. Cells 9:2, pages 421.
Crossref
Crossref
Wali Badar, Thuong Van Ha, Steven Zangan, Rakesh Navuluri, Anjana Pillai, Talia Baker & Osman Ahmed. (2020) Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma. Gastrointestinal Tumors 7:4, pages 144-150.
Crossref
Crossref
Damiano Gentile, Matteo Donadon, Ana Lleo, Alessio Aghemo, Massimo Roncalli, Luca di Tommaso & Guido Torzilli. (2020) Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review. Liver Cancer 9:1, pages 15-27.
Crossref
Crossref
Xindan Kang, Li Bai, Xiaoguang QI & Jing Wang. (2020) Screening and identification of key genes between liver hepatocellular carcinoma (LIHC) and cholangiocarcinoma (CHOL) by bioinformatic analysis. Medicine 99:50, pages e23563.
Crossref
Crossref
Aldona Kasprzak & Agnieszka Adamek. (2019) Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis. International Journal of Molecular Sciences 20:6, pages 1288.
Crossref
Crossref